John Rothman

The first clinical use of a live-attenuated Listeria monocytogenes vaccine: A Phase I safety study of Lm-LLO-E7 in patients with advanced carcinoma of the cervix

Paulo Maciag, Siniša Radulović, John Rothman · Vaccine · 2009 · 320 citations

Vaccination, Vaccine Safety, Vaccine Development +9

Zinc chelation induces rapid depletion of the X-linked inhibitor of apoptosis and sensitizes prostate cancer cells to TRAIL-mediated apoptosis

Peter Makhov, Konstantin Golovine, Robert G. Uzzo et al. · Cell Death and Differentiation · 2008 · 69 citations · Full text

Medicine, Apoptosis, Pharmacology +8

Anti-PD-1 antibody significantly increases therapeutic efficacy of Listeria monocytogenes (Lm)-LLO immunotherapy

Mikayel Mkrtichyan, Namju Chong, Rasha Abu Eid et al. · Journal for ImmunoTherapy of Cancer · 2013 · 68 citations · Full text

<i>Lm</i>-LLO-Based Immunotherapies and HPV-Associated Disease

Anu Wallecha, Chris A. French, Robert G. Petit et al. · Journal of Oncology · 2012 · 51 citations · Full text

Hpv E6, Cervical Cancer, Human Papillomavirus Vaccines +12

A phase II trial of high-dose intravenous interferon alpha-2 in advanced colorectal cancer

R Silgals, James D. Ahlgren, John R. Neefe et al. · Cancer · 1984 · 45 citations · Full text

Surgical Oncology, Phase Ii Trial, Gastrointestinal Oncology +14